CISPLATIN, DOXORUBICIN, AND 5-FU IN COMBINATION FOR ADVANCED GASTRIC-CANCER

被引：0
|
作者：
VOGL, SE [1 ]
ENGSTROM, PF [1 ]
机构：
[1] AMER ONCOL HOSP,PHILADELPHIA,PA 19111
来源：
CANCER TREATMENT REPORTS | 1984年 / 68卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1273 / 1275
页数：3
相关论文
共 50 条
  • [1] PHASE-III STUDY OF 5-FU AND CARMUSTINE VERSUS 5-FU, CARMUSTINE, AND DOXORUBICIN IN ADVANCED GASTRIC-CANCER
    SCHNITZLER, G
    QUEISSER, W
    HEIM, ME
    KONIG, H
    KATZ, R
    FRITZE, D
    HERRMANN, R
    ARNOLD, H
    HENSS, H
    TRUX, FA
    BLOCH, R
    KEYMLING, M
    WOLKEWITZ, KD
    FRITSCH, H
    HANISCH, I
    BRUMEN, L
    EDLER, L
    CANCER TREATMENT REPORTS, 1986, 70 (04): : 477 - 479
  • [2] A PHASE-II TRIAL OF 5-FU, ADRIAMYCIN AND CISPLATIN (FAP) IN ADVANCED GASTRIC-CANCER
    WOOLLEY, P
    SMITH, F
    ESTEVEZ, R
    GISSELBRECHT, C
    ALVAREZ, C
    BOIRON, M
    MACHADO, C
    LAGARDE, C
    SCHEIN, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 455 - 455
  • [3] Efficacy and feasibility of paclitaxel and cisplatin combination chemotherapy for the treatment of 5-flurouracil (5-FU), doxorubicin refractory advanced gastric cancer
    Kim, Y.
    Prrk, B.
    Seo, J.
    Gang, J.
    Lee, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [4] A PROSPECTIVE TRIAL OF 5-FU AND BCNU IN THE TREATMENT OF ADVANCED GASTRIC-CANCER
    JAMIESON, GG
    GILL, PG
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1981, 51 (01): : 16 - 19
  • [5] RANDOMIZED CLINICAL-STUDY WITH MMC AND 5-FU VS MMC, 5-FU AND PSK IN ADVANCED GASTRIC-CANCER
    NAKAO, I
    YOKOYAMA, T
    URUSHIZAKI, I
    WAKUI, A
    FURUE, H
    KOYAMA, Y
    KIMURA, K
    OGAWA, N
    SAITO, T
    INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (03): : 334 - 334
  • [6] Phase II study of paclitaxel, cisplatin, and 5-FU combination chemotherapy in patients with advanced gastric cancer
    Cho, S.
    Shim, H.
    Lee, S.
    Ahn, J.
    Yang, D.
    Kim, Y.
    Park, C.
    Lee, J.
    Chung, I.
    Kim, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] THE EVALUATION OF HIGH-DOSE METHOTREXATE AND 5-FU IN ADVANCED GASTRIC-CANCER
    LEVI, J
    WOODS, R
    MILLIKEN, S
    DICKINSON, R
    MEDICAL AND PEDIATRIC ONCOLOGY, 1985, 13 (03): : 152 - 152
  • [8] ETOPOSIDE, DOXORUBICIN AND CISPLATIN IN ADVANCED OR METASTATIC GASTRIC-CANCER
    MERIMSKY, O
    INBAR, M
    CHAITCHIK, S
    EUROPEAN JOURNAL OF CANCER, 1991, 27 (07) : 944 - 945
  • [9] Postoperative adjuvant 5-FU/cisplatin and chemoradiation with capecitabine for advanced gastric cancer
    Lee, H.
    Choi, Y.
    Hur, W.
    Kown, H.
    Kim, M.
    Jung, G.
    Choi, H-J.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S526 - S526
  • [10] Quality of life in patients with advanced gastric cancer: a randomized trial comparing docetaxel, cisplatin, 5-FU (TCF) with epirubicin, cisplatin, 5-FU (ECF)
    Sadighi, Sanambar
    Mohagheghi, Mohammad Ali
    Montazeri, Ali
    Sadighi, Zahra
    BMC CANCER, 2006, 6 (1)
12345